Canaccord analyst Bobby Burleson downgraded Calyxt to Hold from Buy with an unchanged price target of $1 after Calyxt announced a definitive merger agreement under which the company and Cibus will merge in an all-stock transaction.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLXT: